The aim of this study was to investigate the association of 6-MP related toxicities and other selected polymorphisms of the folate pathway, together with polymorphisms in PACSIN2 and ITPA, which have previously been associated with treatment toxicity12, 14 in children with ALL undergoing 6-MP treatment. The gene discussed is PACSIN2; the disease is acute lymphoblastic leukemia.